Dependence of hydrogen peroxide formation in rat liver microsomes on the molecular structure of cytochrome P-450 substrates: A study with barbiturates and β-adrenoceptor antagonists
- 1 April 1989
- journal article
- research article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 14 (2) , 93-100
- https://doi.org/10.1007/bf03190847
Abstract
In the present study, the molecular structure of xenobiotics has been successfully linked to their effect on the oxidase activity of cytochrome P-450, determined as microsomal hydrogen peroxide formation. A homologous series of 5-alkyl-5-ethyl barbiturates and a heterologous series of β-adrenoceptor antagonists was used. The logarithm of the rate of microsomal hydrogen peroxide formation could be correlated with the logarithm of the apparent partition (n-octanol/buffer) coefficient for the barbiturate derivatives according to a parabolic function. The statistics of the correlation improved considerably by applying a bilinear model in order to fit the data. This probably indicates that both transport of the substrate to cytochrome P-450 and interaction with hydrophobic substrate binding sites of cytochrome P-450 are involved in the modulating effect of substrates on the oxidase function of cytochrome P-450. With the series of β-adrenoceptor antagonists no clear-cut structure activity relationship with regard to the oxidase activity was apparent at first sight. However, when the inhibitory effect of the β-antagonists on the ‘cytochrome P-450 metabolic intermediate (MI) complex’ formation that occurs during the microsomal biotransformation of 33 μM tofenacine was studied a relationship with the lipophilicity could be demonstrated. It is known that MI complex formation occurs with specific subforms of cytochrome P-450. By using this inhibitory activity of the β-adrenoceptor antagonists, the interaction of the compounds becomes restricted to these specific subforms of cytochrome P-450. Li both the oxidase activity as well as the MI complex formation phénobarbital induced cytochrome P-450 is involved. Accordingly a relationship could be established between the percentage of inhibition of microsomal hydrogen peroxide formation and the percentage of inhibition of MI complexation. A distinction between β-antagonists that interact through a ligand or a substrate binding with cytochrome P-450 improved the correlation. Remarkably, d,l-propranolol enhanced the microsomal hydrogen peroxide formation. Both enantiomers of propranolol increased the oxidase activity of cytochrome P-450 to the same extent. The present study demonstrates that prediction of the oxidase activity of cytochrome P-450 is possible provided certain precautions with regard to the specificity of interactions of substrates with cytochrome P-450 are taken into account.This publication has 23 references indexed in Scilit:
- Is formation of reactive oxygen by cytochrome P-450 perilous and predictable?Trends in Pharmacological Sciences, 1986
- On the mechanisms of glutathione depletion in hepatocytes exposed to morphine and ethylmorphineToxicology, 1986
- Mechanisms of lipid peroxidation dependent upon cytochrome P‐450 LM2European Journal of Biochemistry, 1986
- Effect of synthetic antioxidants on hydrogen peroxide formation, oxyferro cytochrome P-450 concentration and oxygen consumption in liver microsomesToxicology, 1985
- Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockersXenobiotica, 1984
- Cytochrome P450 oxidase activity and its role in NADPH dependent lipid peroxidationFEBS Letters, 1983
- Oxidase and Oxygenase Function of the Microsomal Cytochrome P450 Monooxygenase SystemEuropean Journal of Biochemistry, 1982
- Calculation of competitive inhibition of substrate binding to cytochrome P-450 illustrated by the interaction of d,l-propranolol with d,l-hexobarbitalBiochemical Pharmacology, 1980
- Spectral Evidence for Weak Ligand in Sixth Position of Hepatic Microsomal Cytochrome P-450 Low Spin Ferric Iron in vivoPharmacology, 1978
- Ks values of some homologous series of barbiturates and the relationship with the lipophilicity and metabolic clearanceBiochemical Pharmacology, 1977